New study on non-invasive diagnosis of non-melanoma skin cancer with Melanoma Institute of Australia


Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson’s Diagnostics VivoSight system.

Click here to download a pdf copy of the article

(Back to news home)